Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A grey zone for quantitative diagnostic and screening tests.

Joël Coste1, Jacques Pouchot

  • 1Département de Biostatistique, Pavillon Saint-Jacques, Hôpital COCHIN, 27 rue du Faubourg Saint-Jacques, 75674 Paris Cedex 14, France. coste@cochin-univ-paris5.fr

International Journal of Epidemiology
|April 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in prevalence and disability burden of main rheumatic and musculoskeletal diseases in France 2008-2022.

RMD open·2026
Same author

Evolution with age of the relationship between sex and post-COVID symptoms: a population-based cohort study.

BMC medicine·2026
Same author

Association between persistent symptoms and health-related quality of life in the post-COVID-19 condition: a cross-sectional survey in a nationally representative sample of French adults.

Health and quality of life outcomes·2026
Same author

[Tapia syndrome following orotracheal intubation in intensive care unit].

La Revue de medecine interne·2025
Same author

Assessing the burden of osteoporosis and clinical fragility fractures in the French general population: insights from linked healthcare claims and health interview survey data used for surveillance.

Archives of osteoporosis·2025
Same author

Preventing Multimorbidity: Moving Beyond the Single Disease Lens.

International journal of public health·2025
Same journal

Age at menarche and adverse pregnancy and perinatal outcomes: triangulating evidence from multivariable and Mendelian randomization analyses.

International journal of epidemiology·2026
Same journal

Life-course trajectories of cardiovascular disease risk factors in rural India: Andhra Pradesh Children and Parents Study (APCAPS) 2003-2023.

International journal of epidemiology·2026
Same journal

Cohort Profile Update: The Young Lives study.

International journal of epidemiology·2026
Same journal

From the departing Editors in Chief.

International journal of epidemiology·2026
Same journal

Data Resource Profile: Cheeloo Lifespan Electronic-health reseArch Data-library (Cheeloo LEAD).

International journal of epidemiology·2026
Same journal

Cohort Profile Update: The Swiss Childhood Cancer Survivor Cohort.

International journal of epidemiology·2026
See all related articles

This study introduces a novel three-zone partition for quantitative diagnostic tests, incorporating a grey zone to improve disease status determination. This method enhances the interpretation of test performance and variability in clinical and screening settings.

Area of Science:

  • Biostatistics
  • Medical Diagnostics
  • Quantitative Analysis

Background:

  • Quantitative diagnostic tests often lack perfect discrimination between healthy and diseased individuals.
  • Binary (positive/negative) test results may not reflect the uncertainty inherent in clinical practice.
  • A 'grey zone' approach is proposed to address the limitations of traditional binary classifications.

Purpose of the Study:

  • To develop a method for constructing a three-zone partition for quantitative tests.
  • To introduce a 'grey zone' that acknowledges uncertainty in disease status determination.
  • To move beyond the binary constraints of traditional diagnostic test interpretation.

Main Methods:

  • A three-zone partition is proposed for quantitative tests, including distinct negative, positive, and grey zones.

Related Experiment Videos

  • The width of the grey zone is determined by factors such as mean differences, test variability, and acceptable misclassification risks.
  • The method is illustrated using the tuberculin skin test and iron deficiency markers.

    • Main Results:

    • The width of the grey zone is influenced by the difference in means between diseased and non-diseased groups.
    • Test result variability (biological and measurement) directly impacts the grey zone's size.
    • The acceptable levels of false positive and false negative risks are critical determinants of the grey zone width.

    Conclusions:

    • The proposed method aids in displaying and scrutinizing the discriminatory performance and variability of quantitative tests.
    • Graphical representations of the grey zone approach offer simplicity and utility.
    • This method is valuable for developing new quantitative tests and publishing their performance characteristics.